Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Bronchial Basal Cell Transplantation for COPD
NCT03092648Phase 2Unknown
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Mar 2017
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
Phase 2, open-label trial in chronic obstructive pulmonary disease (COPD), sponsored by Nanfang Hospital, Southern Medical University. Primary endpoint: Forced Expiratory Volume in 1 Second at 6 months. Status: unknown.
02
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03092648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03092648.